Interactions of alcuronium, TMB-8, and other allosteric ligands with muscarinic acetylcholine receptors: Studies with chimeric receptors

John Ellis, Margaret Seidenberg

Research output: Contribution to journalShort survey

50 Citations (Scopus)

Abstract

A series of ligands that allosterically modulate the binding of classical ligands to muscarinic receptors was evaluated at wild-type and chimeric receptors. All of the ligands studied had highest affinity toward the M2 subtype and lowest affinity toward the M5 subtype. The chimeric receptors were mostly M5 sequence; the amount of M2 sequence ranged from about 6 to just under 30%. Alcuronium and TMB-8 had much higher affinity for the chimeric receptor that included the M2 second outer loop of the receptor plus flanking regions of TM4 and TM5 than for any of the other chimeric receptors (the affinities of which remained similar to that of the M5 subtype). However, this chimera retained the negative cooperativity between alcuronium and the classical antagonist N-methylscopolamine that is characteristic of M5 (these ligands are positively cooperative at M2). Verapamil, tetrahydroaminoacridine, and d-tubocurarine were also sensitive to that chimeric substitution, although verapamil and tetrahydroaminoacridine had even higher affinity for a chimera with M2 sequence in TM7. None of these ligands shared gallamine's sensitivity to a region of the third outer loop, but studies in which obidoxime reversed the allosteric effects of gallamine and other ligands suggested that they nevertheless compete for a common site. In summary, although the present data are consistent with previous studies that have suggested that allosteric ligands bind to the outermost regions of muscarinic receptors, it appears that different allosteric ligands may derive subtype selectivity from different regions of the receptor.

Original languageEnglish (US)
Pages (from-to)1451-1460
Number of pages10
JournalMolecular pharmacology
Volume58
Issue number6
DOIs
StatePublished - Jan 1 2000

Fingerprint

Alcuronium
Muscarinic Receptors
Ligands
Gallamine Triethiodide
Tacrine
Verapamil
Obidoxime Chloride
N-Methylscopolamine
Tubocurarine
8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology

Cite this

@article{51349c4bfd224f3f8eab82184d63931f,
title = "Interactions of alcuronium, TMB-8, and other allosteric ligands with muscarinic acetylcholine receptors: Studies with chimeric receptors",
abstract = "A series of ligands that allosterically modulate the binding of classical ligands to muscarinic receptors was evaluated at wild-type and chimeric receptors. All of the ligands studied had highest affinity toward the M2 subtype and lowest affinity toward the M5 subtype. The chimeric receptors were mostly M5 sequence; the amount of M2 sequence ranged from about 6 to just under 30{\%}. Alcuronium and TMB-8 had much higher affinity for the chimeric receptor that included the M2 second outer loop of the receptor plus flanking regions of TM4 and TM5 than for any of the other chimeric receptors (the affinities of which remained similar to that of the M5 subtype). However, this chimera retained the negative cooperativity between alcuronium and the classical antagonist N-methylscopolamine that is characteristic of M5 (these ligands are positively cooperative at M2). Verapamil, tetrahydroaminoacridine, and d-tubocurarine were also sensitive to that chimeric substitution, although verapamil and tetrahydroaminoacridine had even higher affinity for a chimera with M2 sequence in TM7. None of these ligands shared gallamine's sensitivity to a region of the third outer loop, but studies in which obidoxime reversed the allosteric effects of gallamine and other ligands suggested that they nevertheless compete for a common site. In summary, although the present data are consistent with previous studies that have suggested that allosteric ligands bind to the outermost regions of muscarinic receptors, it appears that different allosteric ligands may derive subtype selectivity from different regions of the receptor.",
author = "John Ellis and Margaret Seidenberg",
year = "2000",
month = "1",
day = "1",
doi = "10.1124/mol.58.6.1451",
language = "English (US)",
volume = "58",
pages = "1451--1460",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "6",

}

Interactions of alcuronium, TMB-8, and other allosteric ligands with muscarinic acetylcholine receptors : Studies with chimeric receptors. / Ellis, John; Seidenberg, Margaret.

In: Molecular pharmacology, Vol. 58, No. 6, 01.01.2000, p. 1451-1460.

Research output: Contribution to journalShort survey

TY - JOUR

T1 - Interactions of alcuronium, TMB-8, and other allosteric ligands with muscarinic acetylcholine receptors

T2 - Studies with chimeric receptors

AU - Ellis, John

AU - Seidenberg, Margaret

PY - 2000/1/1

Y1 - 2000/1/1

N2 - A series of ligands that allosterically modulate the binding of classical ligands to muscarinic receptors was evaluated at wild-type and chimeric receptors. All of the ligands studied had highest affinity toward the M2 subtype and lowest affinity toward the M5 subtype. The chimeric receptors were mostly M5 sequence; the amount of M2 sequence ranged from about 6 to just under 30%. Alcuronium and TMB-8 had much higher affinity for the chimeric receptor that included the M2 second outer loop of the receptor plus flanking regions of TM4 and TM5 than for any of the other chimeric receptors (the affinities of which remained similar to that of the M5 subtype). However, this chimera retained the negative cooperativity between alcuronium and the classical antagonist N-methylscopolamine that is characteristic of M5 (these ligands are positively cooperative at M2). Verapamil, tetrahydroaminoacridine, and d-tubocurarine were also sensitive to that chimeric substitution, although verapamil and tetrahydroaminoacridine had even higher affinity for a chimera with M2 sequence in TM7. None of these ligands shared gallamine's sensitivity to a region of the third outer loop, but studies in which obidoxime reversed the allosteric effects of gallamine and other ligands suggested that they nevertheless compete for a common site. In summary, although the present data are consistent with previous studies that have suggested that allosteric ligands bind to the outermost regions of muscarinic receptors, it appears that different allosteric ligands may derive subtype selectivity from different regions of the receptor.

AB - A series of ligands that allosterically modulate the binding of classical ligands to muscarinic receptors was evaluated at wild-type and chimeric receptors. All of the ligands studied had highest affinity toward the M2 subtype and lowest affinity toward the M5 subtype. The chimeric receptors were mostly M5 sequence; the amount of M2 sequence ranged from about 6 to just under 30%. Alcuronium and TMB-8 had much higher affinity for the chimeric receptor that included the M2 second outer loop of the receptor plus flanking regions of TM4 and TM5 than for any of the other chimeric receptors (the affinities of which remained similar to that of the M5 subtype). However, this chimera retained the negative cooperativity between alcuronium and the classical antagonist N-methylscopolamine that is characteristic of M5 (these ligands are positively cooperative at M2). Verapamil, tetrahydroaminoacridine, and d-tubocurarine were also sensitive to that chimeric substitution, although verapamil and tetrahydroaminoacridine had even higher affinity for a chimera with M2 sequence in TM7. None of these ligands shared gallamine's sensitivity to a region of the third outer loop, but studies in which obidoxime reversed the allosteric effects of gallamine and other ligands suggested that they nevertheless compete for a common site. In summary, although the present data are consistent with previous studies that have suggested that allosteric ligands bind to the outermost regions of muscarinic receptors, it appears that different allosteric ligands may derive subtype selectivity from different regions of the receptor.

UR - http://www.scopus.com/inward/record.url?scp=0033664285&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033664285&partnerID=8YFLogxK

U2 - 10.1124/mol.58.6.1451

DO - 10.1124/mol.58.6.1451

M3 - Short survey

C2 - 11093785

AN - SCOPUS:0033664285

VL - 58

SP - 1451

EP - 1460

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 6

ER -